Elevated physiologic tumor pressure promotes proliferation and chemosensitivity in human osteosarcoma

Saminathan S. Nathan, Gene R. DiResta, Jorge E. Casas-Ganem, Bang H. Hoang, Rebecca Sowers, Rui Yang, Andrew G. Huvos, Richard Gorlick, John H. Healey

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Purpose: This study investigates the effect of constitutively raised interstitial fluid pressure on osteosarcoma physiology and chemosensitivity. Experimental Design: We did pressure and blood flow assessments at the time of open biopsy in patients with the diagnosis of high-grade osteosarcoma and correlated this to survival and chemotherapy-associated tumor necrosis. Osteosarcoma cell lines were then evaluated for proliferative and therapeutic indices in a replicated high-pressure environment. Results: Sixteen osteosarcomas in vivo were assessed and exhibited elevated interstitial fluid pressures (mean 35.2 ± SD, 18.6 mmHg). This was not associated with significantly impeded blood flow as measured by a Doppler probe at a single site (P < 0.12). Nonetheless, greater chemotherapy-associated necrosis and associated longer survival were seen in tumors with higher interstitial fluid pressures (P < 0.05). In vitro, cells undergo significant physiologic changes under pressure. Osteosarcoma cell lines grown in a novel hydrostatically pressurized system had variable cell line-specific growth proportional to the level of pressure. They were more proliferative as indicated by cell cycle analysis with more cells in S phase after 48 hours of pressurization (P < 0.01). There was a significant elevation in the cell cycle-related transcription factors E2F-1 (P < 0.03) and E2F-4 (P < 0.002). These changes were associated with increased chemosensitivity. Cells tested under pressure showed an increased sensitivity to cisplatin (P < 0.00006) and doxorubicin (P < 0.03) reminiscent of the increased chemotherapy-associated necrosis seen in tumors with higher interstitial fluid pressure in the clinical study. Conclusions: The results of this study suggest that cells in the in vivo pressurized environment are at a higher state of regenerative activity than is demonstrable in conventional cell culture systems. Variations in tumor interstitial fluid pressure have the potential to alter chemotherapeutic effects.

Original languageEnglish (US)
Pages (from-to)2389-2397
Number of pages9
JournalClinical Cancer Research
Volume11
Issue number6
DOIs
StatePublished - Mar 15 2005
Externally publishedYes

Fingerprint

Osteosarcoma
Pressure
Extracellular Fluid
Neoplasms
Necrosis
Drug Therapy
Cell Line
Cell Cycle
E2F1 Transcription Factor
Survival
S Phase
Doxorubicin
Cisplatin
Research Design
Cell Culture Techniques
Blood Pressure
Biopsy
Growth

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Elevated physiologic tumor pressure promotes proliferation and chemosensitivity in human osteosarcoma. / Nathan, Saminathan S.; DiResta, Gene R.; Casas-Ganem, Jorge E.; Hoang, Bang H.; Sowers, Rebecca; Yang, Rui; Huvos, Andrew G.; Gorlick, Richard; Healey, John H.

In: Clinical Cancer Research, Vol. 11, No. 6, 15.03.2005, p. 2389-2397.

Research output: Contribution to journalArticle

Nathan, SS, DiResta, GR, Casas-Ganem, JE, Hoang, BH, Sowers, R, Yang, R, Huvos, AG, Gorlick, R & Healey, JH 2005, 'Elevated physiologic tumor pressure promotes proliferation and chemosensitivity in human osteosarcoma', Clinical Cancer Research, vol. 11, no. 6, pp. 2389-2397. https://doi.org/10.1158/1078-0432.CCR-04-2048
Nathan, Saminathan S. ; DiResta, Gene R. ; Casas-Ganem, Jorge E. ; Hoang, Bang H. ; Sowers, Rebecca ; Yang, Rui ; Huvos, Andrew G. ; Gorlick, Richard ; Healey, John H. / Elevated physiologic tumor pressure promotes proliferation and chemosensitivity in human osteosarcoma. In: Clinical Cancer Research. 2005 ; Vol. 11, No. 6. pp. 2389-2397.
@article{539ff7a0f87945bcab49bc0eb28b02ff,
title = "Elevated physiologic tumor pressure promotes proliferation and chemosensitivity in human osteosarcoma",
abstract = "Purpose: This study investigates the effect of constitutively raised interstitial fluid pressure on osteosarcoma physiology and chemosensitivity. Experimental Design: We did pressure and blood flow assessments at the time of open biopsy in patients with the diagnosis of high-grade osteosarcoma and correlated this to survival and chemotherapy-associated tumor necrosis. Osteosarcoma cell lines were then evaluated for proliferative and therapeutic indices in a replicated high-pressure environment. Results: Sixteen osteosarcomas in vivo were assessed and exhibited elevated interstitial fluid pressures (mean 35.2 ± SD, 18.6 mmHg). This was not associated with significantly impeded blood flow as measured by a Doppler probe at a single site (P < 0.12). Nonetheless, greater chemotherapy-associated necrosis and associated longer survival were seen in tumors with higher interstitial fluid pressures (P < 0.05). In vitro, cells undergo significant physiologic changes under pressure. Osteosarcoma cell lines grown in a novel hydrostatically pressurized system had variable cell line-specific growth proportional to the level of pressure. They were more proliferative as indicated by cell cycle analysis with more cells in S phase after 48 hours of pressurization (P < 0.01). There was a significant elevation in the cell cycle-related transcription factors E2F-1 (P < 0.03) and E2F-4 (P < 0.002). These changes were associated with increased chemosensitivity. Cells tested under pressure showed an increased sensitivity to cisplatin (P < 0.00006) and doxorubicin (P < 0.03) reminiscent of the increased chemotherapy-associated necrosis seen in tumors with higher interstitial fluid pressure in the clinical study. Conclusions: The results of this study suggest that cells in the in vivo pressurized environment are at a higher state of regenerative activity than is demonstrable in conventional cell culture systems. Variations in tumor interstitial fluid pressure have the potential to alter chemotherapeutic effects.",
author = "Nathan, {Saminathan S.} and DiResta, {Gene R.} and Casas-Ganem, {Jorge E.} and Hoang, {Bang H.} and Rebecca Sowers and Rui Yang and Huvos, {Andrew G.} and Richard Gorlick and Healey, {John H.}",
year = "2005",
month = "3",
day = "15",
doi = "10.1158/1078-0432.CCR-04-2048",
language = "English (US)",
volume = "11",
pages = "2389--2397",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "6",

}

TY - JOUR

T1 - Elevated physiologic tumor pressure promotes proliferation and chemosensitivity in human osteosarcoma

AU - Nathan, Saminathan S.

AU - DiResta, Gene R.

AU - Casas-Ganem, Jorge E.

AU - Hoang, Bang H.

AU - Sowers, Rebecca

AU - Yang, Rui

AU - Huvos, Andrew G.

AU - Gorlick, Richard

AU - Healey, John H.

PY - 2005/3/15

Y1 - 2005/3/15

N2 - Purpose: This study investigates the effect of constitutively raised interstitial fluid pressure on osteosarcoma physiology and chemosensitivity. Experimental Design: We did pressure and blood flow assessments at the time of open biopsy in patients with the diagnosis of high-grade osteosarcoma and correlated this to survival and chemotherapy-associated tumor necrosis. Osteosarcoma cell lines were then evaluated for proliferative and therapeutic indices in a replicated high-pressure environment. Results: Sixteen osteosarcomas in vivo were assessed and exhibited elevated interstitial fluid pressures (mean 35.2 ± SD, 18.6 mmHg). This was not associated with significantly impeded blood flow as measured by a Doppler probe at a single site (P < 0.12). Nonetheless, greater chemotherapy-associated necrosis and associated longer survival were seen in tumors with higher interstitial fluid pressures (P < 0.05). In vitro, cells undergo significant physiologic changes under pressure. Osteosarcoma cell lines grown in a novel hydrostatically pressurized system had variable cell line-specific growth proportional to the level of pressure. They were more proliferative as indicated by cell cycle analysis with more cells in S phase after 48 hours of pressurization (P < 0.01). There was a significant elevation in the cell cycle-related transcription factors E2F-1 (P < 0.03) and E2F-4 (P < 0.002). These changes were associated with increased chemosensitivity. Cells tested under pressure showed an increased sensitivity to cisplatin (P < 0.00006) and doxorubicin (P < 0.03) reminiscent of the increased chemotherapy-associated necrosis seen in tumors with higher interstitial fluid pressure in the clinical study. Conclusions: The results of this study suggest that cells in the in vivo pressurized environment are at a higher state of regenerative activity than is demonstrable in conventional cell culture systems. Variations in tumor interstitial fluid pressure have the potential to alter chemotherapeutic effects.

AB - Purpose: This study investigates the effect of constitutively raised interstitial fluid pressure on osteosarcoma physiology and chemosensitivity. Experimental Design: We did pressure and blood flow assessments at the time of open biopsy in patients with the diagnosis of high-grade osteosarcoma and correlated this to survival and chemotherapy-associated tumor necrosis. Osteosarcoma cell lines were then evaluated for proliferative and therapeutic indices in a replicated high-pressure environment. Results: Sixteen osteosarcomas in vivo were assessed and exhibited elevated interstitial fluid pressures (mean 35.2 ± SD, 18.6 mmHg). This was not associated with significantly impeded blood flow as measured by a Doppler probe at a single site (P < 0.12). Nonetheless, greater chemotherapy-associated necrosis and associated longer survival were seen in tumors with higher interstitial fluid pressures (P < 0.05). In vitro, cells undergo significant physiologic changes under pressure. Osteosarcoma cell lines grown in a novel hydrostatically pressurized system had variable cell line-specific growth proportional to the level of pressure. They were more proliferative as indicated by cell cycle analysis with more cells in S phase after 48 hours of pressurization (P < 0.01). There was a significant elevation in the cell cycle-related transcription factors E2F-1 (P < 0.03) and E2F-4 (P < 0.002). These changes were associated with increased chemosensitivity. Cells tested under pressure showed an increased sensitivity to cisplatin (P < 0.00006) and doxorubicin (P < 0.03) reminiscent of the increased chemotherapy-associated necrosis seen in tumors with higher interstitial fluid pressure in the clinical study. Conclusions: The results of this study suggest that cells in the in vivo pressurized environment are at a higher state of regenerative activity than is demonstrable in conventional cell culture systems. Variations in tumor interstitial fluid pressure have the potential to alter chemotherapeutic effects.

UR - http://www.scopus.com/inward/record.url?scp=16844376641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16844376641&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-04-2048

DO - 10.1158/1078-0432.CCR-04-2048

M3 - Article

C2 - 15788690

AN - SCOPUS:16844376641

VL - 11

SP - 2389

EP - 2397

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 6

ER -